10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
Stockholder Meeting Results - Board Election and Compensation Approved
Announces First Quarter 2026 Financial Results and Pipeline Progress
Financial Results, Press Release
CFO Departure - Andy Sassine Steps Down from Arcturus Therapeutics
Announces Third Quarter 2025 Financial Update and Pipeline Progress
Investor Presentation
Reg. FD
Q1
FY 2025
Q3
Notice of Late Filing for Quarterly Report
Q2
FY 2024
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload
Delisting Amendment